News

Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.
HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, HopeAI ...
In July 2025, Mersana made a payment of approximately $17.9 million to satisfy in full its indebtedness and obligations under the company’s previous loan and security agreement. The company continues ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...
Radiation therapy may account for half of all new cancers among the growing population of childhood cancer survivors, according to a study published Aug. 11 in the Journal of Clinical Oncology. With ...
The American Cancer Society (ACS) has awarded The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai a $4.08 million grant to establish the Cancer Health Research Center at Mount ...
More and more providers are beginning to incorporate the new Practical Geriatric Assessment into their practices.
Two new studies show that colorectal cancer screening sharply increased for people ages 45 to 49 after the age recommendation ...
On June 2, UroGen Pharma Ltd. (NASDAQ:URGN) presented its uTRACT Registry study design at the 2025 American Society of Clinical Oncology.
CINCINNATI (WKRC) - The American Cancer Society says transportation is the number one barrier to treatment. That's why there's a program to give free rides to patients.
In Greenville, the American Cancer Society has introduced a new initiative at the McConnell-Raab Hope Lodge in Greenville, aiming to alleviate transportation barriers for cancer patients seeking ...